Thursday, 27 January, 2022


Opioid use and vaping show medical community’s failure to respect addiction as a disease

Doctors, insurance companies, and regulators have not managed to balance the risks of addiction with the benefits of alleviating pain or helping a patient quit smoking.

Modi govt’s Ayushman Bharat likely to cover over 90 cr people — 70% of total population

The scheme covers 40% of the population at present. Official document accessed by ThePrint says the government will expand the scheme over time.

Danish firm gets FDA approval for oral diabetes pill, no word yet on India launch

India has 7.2 crore people with diabetes and oral pills will help them avoid the pain of puncturing themselves again and again.

E-cigarettes banned after Union Cabinet approves ordinance

Finance Minister Nirmala Sitharaman said the Cabinet decided to ban the sale, production, and import of e-cigarettes as they pose health risk to people.

Modi govt now wants to open its cheap drug stores in tribal & remote rural areas

Govt has set a target of opening nearly 5,000 Jan Aushadhi Kendras in the next 5 years in the NE, Andaman & Nicobar Islands and Lakshadweep.

Dehradun battles dengue outbreak as cases spike from 712 to 1,788 in past 10 days

Uttarakhand, which has seen 6 dengue deaths, has reported 2,600 cases since July from areas like Nainital, Haridwar, Udham Singh Nagar and Tehri Garhwal.

India again lobbies with Beijing to sell its generic medicines amid US-China trade war

Modi govt has asked China to provide quick clearances for made-in-India drugs at the India-China Strategic Economic Dialogue meet held between 7-9 September.

Popular acidity drug has cancer-causing substance, says US health regulator

The drug, Ranitidine, is available in India under the brand names of ‘Aciloc’ and ‘Zinetac’.

Thinking of avoiding social media and putting down your phone? Technostress won’t let you

Before you know it, you may have spent minutes or even hours of “dead” time doing nothing other than flitting from one function to another to divert yourself.

Sun Pharmaceuticals undergoes SEBI-ordered forensic audit

The latest probe points to challenges for India’s biggest drugmaker after whistle-blower complaints on corporate governance lapses triggered a stock slide last year.

On Camera


Covid isn’t behind us, but the world’s next big health emergency is already here

Covid has led to 5.6 million deaths, but antimicrobial resistance is likely to log 10 million deaths annually by 2050. Its treatment has led to antibiotics' overuse, which has spiked drug resistance.
An Assicurazioni Generali SpA logo sits above an entrance to their offices in Rome | Bloomberg

Italian Generali buys 25% stake worth Rs 1,250 cr in insurance JV from embattled Future Group

The stake sale, which will give Generali majority control over the JV, comes as the Future Group is locked in a prolonged legal battle with partner Amazon.


The Indian Army's Akash missiles on display during the 73rd Republic Day Parade, at Rajpath, in New Delhi | ANI

Not just 1st R-Day, 26 Jan 1950 also significant as Indian Army, Navy shed ‘Royal’ prefix

Both the ‘Royal’ prefix for the Navy and Air Force in India, as well as the absence of such a label for the Army, have their roots in British military and political history.

Modi vs non-BJP CMs: When most popular isn’t all-powerful & why Centre-state ties will worsen

Modi’s inability to win many states, and the huge popularity his rivals enjoy there, is pushing Indian politics in a more robustly federal direction.